Ilex Capital Partners (Uk) LLP Viatris Inc Transaction History
Ilex Capital Partners (Uk) LLP
- $2.45 Trillion
- Q1 2025
A detailed history of Ilex Capital Partners (Uk) LLP transactions in Viatris Inc stock. As of the latest transaction made, Ilex Capital Partners (Uk) LLP holds 212,052 shares of VTRS stock, worth $1.76 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
212,052Holding current value
$1.76 Million% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding VTRS
# of Institutions
1,138Shares Held
953MCall Options Held
4.15MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$768 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$617 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az64.9MShares$538 Million3.35% of portfolio
-
State Street Corp Boston, MA61.5MShares$509 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $10.1B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...